Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rajiv Gandhi Cancer Institute and Research Centre (RGCI&RC) is a premier non-profit tertiary care hospital and research facility dedicated to oncology, located in New Delhi, India. Established in 1996 as a project of the Indraprastha Cancer Society and Research Centre, it has grown into one of Asia's largest centers for specialized cancer treatment. The institute provides comprehensive services across surgical, medical, and radiation oncology, featuring advanced technologies such as robotic surgery, bone marrow transplantation, and molecular diagnostics. Beyond clinical care, RGCI&RC is a significant hub for clinical research, participating in global multi-center trials and conducting indigenous studies to improve cancer outcomes. It is accredited by NABH and NABL, maintaining high standards of patient safety and quality in healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rajiv Gandhi Cancer Institute and Research Centre.